FDA Inspection 1055183 — Maximino Bello III, M.D.
The FDA completed an inspection of Maximino Bello III, M.D. on May 4, 2018 in Quezon City. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 4, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Quezon City (Philippines)
Additional Details
Clinical Investigator (CI)